Gabriele Gamerith

Innsbruck, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Paclitaxel plus cetuximab for the treatment of R/M SCCHN after first-line pembrolizumab failure: primary analysis from the PaceAce trial.

Paclitaxel plus cetuximab for the treatment of R/M SCCHN after first-line pembrolizumab failure: primary analysis from the PaceAce trial.

Journal: ESMO open

Published: August 25, 2025

Erratum: [Corrigendum] The impact of metformin and salinomycin on transforming growth factor β-induced epithelial-to-mesenchymal transition in non-small cell lung cancer cell lines.

Erratum: [Corrigendum] The impact of metformin and salinomycin on transforming growth factor β-induced epithelial-to-mesenchymal transition in non-small cell lung cancer cell lines.

Journal: Oncology letters

Published: July 04, 2025

Prognostic impact of targetable driver alterations in resected early-stage lung cancer.

Prognostic impact of targetable driver alterations in resected early-stage lung cancer.

Journal: Translational lung cancer research

Published: May 16, 2024

Soluble PD-L1 shows no association to relapse and overall survival in early stage non-small cell lung cancer (NSCLC).

Soluble PD-L1 shows no association to relapse and overall survival in early stage non-small cell lung cancer (NSCLC).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: April 05, 2024

Whole stromal fibroblast signature is linked to specific chemokine and immune infiltration patterns and to improved survival in NSCLC.

Whole stromal fibroblast signature is linked to specific chemokine and immune infiltration patterns and to improved survival in NSCLC.

Journal: Oncoimmunology

Published: December 21, 2023

Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for Head and Neck Cancer.

Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for Head and Neck Cancer.

Journal: Anticancer research

Published: January 05, 2023

Molecular Characteristics of Radon Associated Lung Cancer Highlights MET Alterations.

Molecular Characteristics of Radon Associated Lung Cancer Highlights MET Alterations.

Journal: Cancers

Published: September 15, 2022

High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancer.

High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancer.

Journal: Cancer cell

Published: May 09, 2022

Functional Outcomes in Head and Neck Cancer Patients.

Functional Outcomes in Head and Neck Cancer Patients.

Journal: Cancers

Published: March 16, 2022

Association of baseline soluble immune checkpoints with the risk of relapse in PR3-ANCA vasculitis following induction of remission.

Association of baseline soluble immune checkpoints with the risk of relapse in PR3-ANCA vasculitis following induction of remission.

Journal: Annals of the rheumatic diseases

Published: March 15, 2022

Efficacy and safety of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) monotherapy for advanced EGFR-mutated non-small cell lung cancer: systematic review and meta-analysis.

Efficacy and safety of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) monotherapy for advanced EGFR-mutated non-small cell lung cancer: systematic review and meta-analysis.

Journal: European review for medical and pharmacological sciences

Published: November 03, 2021

Hepatobiliary Adverse Drug Reactions Associated With Remdesivir: The WHO International Pharmacovigilance Study.

Hepatobiliary Adverse Drug Reactions Associated With Remdesivir: The WHO International Pharmacovigilance Study.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: March 18, 2021

Showing 1-12 of 39

Last Updated: 09/26/2026